The EVANTHEA Study demonstrated that a personalized Precision Medicine approach addressing multiple contributors to cognitive decline may improve memory, executive function, processing speed, physical health, and quality of life in individuals with Mild Cognitive Impairment and early Alzheimer’s disease. The study supports a systems-based approach that evaluates factors such as inflammation, metabolism, sleep, hormones, nutrition, stress, and environmental exposures rather than focusing on a single target alone.